Pancreatic Malignant Neoplasm Primary
Conditions
Keywords
Failure Adjuvant Therapy
Brief summary
This study aims to evaluate the rate of patients submitted to pancreatic resection for pancreatic cancer, who fail to access to adjuvant therapy or do not complete adjuvant therapy. The purpose is to give an overview concerning the most frequent conditions and/or reasons associated with failure or omission of adjuvant therapy.
Detailed description
This prospective observational study will evaluate all patients submitted to pancreatic resection for pancreatic cancer. The rate of omission to adjuvant therapy and rate of failure of completion of adjuvant therapy will be evaluated as primary outcomes. As secondary outcomes, survival analyses will be performed to investigate whether these factors influence prognosis, that will be evaluated through a disease free survival analysis at 18-months. Epidemiological and perioperative data will be analyzed to identify conditions associated with the primary outcomes.
Interventions
None listed
Sponsors
Universita di Verona
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Histologic diagnosis of pancreatic cancer
Exclusion criteria
* Non exocrine pancreatic tumors * Periampullary malignancies
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of patients who fail to receive adjuvant therapy and reasons for that | 6 months | The amount of patients who will not receive adjuvant therapy after pancreatic resection for malignancy (when do indication exists) will be recorded |
| Rate of patients who fail to complete adjuvant therapy and reasons for that | 9 months | The amount of patients who will not complete adjuvant therapy after pancreatic resection for malignancy will be recorded |
Secondary
| Measure | Time frame |
|---|---|
| Disease free survival of patients enrolled | 18 months |
Countries
Italy
Outcome results
None listed